2025 · 1st Quarter (Jan 1 - Mar 31)
Filed by THE NICKLES GROUP, LLC.
Open official filingSource-reported fields
Literal source text
Monitored issues related to pharmaceutical prices. Issues related to dialysis. Issues regarding the pharmaceutical supply chain. Monitored issues concerning drug shortages. Issues concerning the reauthorization of Pandemic and All-Hazards Preparedness and Response Act (PAHPA). Monitored AI issues. Monitored cybersecurity issues. Issues concerning Hurricane Helene. H.R. 1968 (P.L. 119-4), Full-Year Continuing Appropriations and Extensions Act, 2025.
Literal federal measure citations: H.R. 1968
Issues related to tariffs.
Issues related to ESRD, including increasing home dialysis. Implementation of drug pricing provisions related to H.R. 5376 (P.L. 117-169), The Inflation Reduction Act. Monitored issues related to safe mobility. Issues related to reimbursement for breakthrough devices. Issues related to drug shortages. Issues related to extension of the hospital at home program.
Literal federal measure citations: H.R. 5376
Monitored H.R. 1990, the American Innovation and R&D Competitiveness Act, and issues related to the R&D tax credit. Monitor issues related to the expiration of the 2017 Tax Cut & Jobs Act.
Literal federal measure citations: H.R. 1990
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
